<DOC>
	<DOCNO>NCT01337323</DOCNO>
	<brief_summary>This study prospective observational cohort study 3-month follow-up among cohort intranasal steroid ( INS ) -experienced patient newly start fluticasone furorate nasal spray ( FFNS ) . The primary aim examine effect FFNS use associate cost concomitant allergic rhinitis medication INS-experienced patient start treatment FFNS history prior concomitant medication use . The secondary aim determine effect FFNS control allergic rhinitis , assess Rhinitis Control Assessment Test ( RCAT ) . Adult patient fill new FFNS prescription recruit ( within 4 day start FFNS ) across 50 branch retail pharmacy chain co-located convenient care clinic . Approximately 350 patient active seasonal rhinitis use INS FFNS another prescription over-the-counter allergy medication previous allergy season eligible study . A baseline questionnaire administer collect information patient demographic , brief medical history patient 's rhinitis , prior use INS prescription over-the-counter medication take allergic rhinitis , total pocket cost prior allergy season , number office visit due allergic rhinitis , level control symptoms allergic rhinitis . At 1 , 2 , 3 month post-enrollment , follow-up questionnaire administer collect information medication take allergic rhinitis , office visit due rhinitis , level control symptoms allergic rhinitis . In addition , pharmacy claim data abstract patient 1 year prior enrollment 4 month enrollment verify supplement patient report data need . The primary outcome rate use non-INS concomitant medication ( frequency duration ) baseline , 1 , 2 , 3 month follow-up change rate use non-INS concomitant medication ( post vs. pre baseline 3 month follow-up ) . Secondary outcome change total allergic rhinitis pharmacy expenditure ( post vs. pre baseline follow-up ) change level control allergic rhinitis , measure score Rhinitis Control Assessment Test ( RCAT ) , baseline follow-up .</brief_summary>
	<brief_title>Prospective Observational Study Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting Fluticasone Furoate Nasal Spray Retail Pharmacy Setting</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Active seasonal allergic rhinitis Initiating firsttime treatment fluticasone furoate nasal spray ( FFNS ) Received treatment least one intranasal steroid ( INS ) FFNS last allergy season Received treatment one antihistamine , leukotriene receptor atagonists ( LTRA ) , topical ocular medication , counter ( OTC ) medication allergic rhinitis symptom last allergy season At least 18 year age time study enrollment Able read , comprehend , record information English Have provide appropriately sign date informed consent Received prior treatment FFNS Pregnant Employee family member employee study sponsor , retail pharmacy chain , convenient care clinic implementing study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>allergic rhinitis , allergy , concomitant medication , allergy symptom</keyword>
</DOC>